Disease | intracranial hypertension |
Phenotype | C0033845|benign intracranial hypertension |
Sentences | 9 |
PubMedID- 24379555 | [1] formerly known as benign intracranial hypertension or pseudo tumor cerebri, iih is a diagnosis of exclusion made in the presence of papilledema, normal neuroimaging, and cerebrospinal fluid (csf) analysis but with an elevated csf opening pressure. |
PubMedID- 21633609 | [1] the term benign intracranial hypertension had been used for several decades in consideration of the relatively benign course and likelihood of recovery without major sequelae. |
PubMedID- 20169131 | Benign intracranial hypertension (bih) has been seen in 4% of patients with gh receptor deficiency or gh inactivating antibodies treated with rhigf-1, for an estimated 90/10,000 patient years [18]; recent data from the tercica clinical trial provide a similar rate of 140/10,000 patient years for those receiving therapeutic doses [24]. |
PubMedID- 24834925 | Also, 5 of the 22 saes (benign intracranial hypertension, uveitis, urinary calculus, pneumonia, cellulitis) in 5 (2.7%) patients were considered by the investigator to be related to tocilizumab. |
PubMedID- 20436745 | Benign intracranial hypertension is a common cause of papilledema in young, overweight females. |
PubMedID- 23761782 | Benign intracranial hypertension (pseudotumor cerebri) has been linked to gh treatment in children (malozowski and stadel, 1995) but is rare in adults, with only one case reported (malozowski et al., 1993). |
PubMedID- 22497990 | The benign intracranial hypertension is always related, in our experience of 64 cases, to cerebral venous thrombosis [20]. |
PubMedID- 22518165 | Benign intracranial hypertension or pseudotumour cerebri is a unique syndrome seen mostly in obese young women, and pregnancy has been identified as a risk factor [98]. |
PubMedID- 24653894 | Benign intracranial hypertension usually shows in young obese females, and symptoms include pulsatile tinnitus, headaches, blurred vision among other non-characteristic symptoms. |
Page: 1